Treatment with bezuclastinib plus Sutent led to safe and efficacious outcomes versus Sutent treatment alone in gastrointestinal stromal tumors.

Researchers from Tokyo Metropolitan University have developed a new dye that can strongly absorb second near-IR radiation and ...

[25] In view of these data, imatinib has become the first-line treatment for patients presenting with advanced GIST. Since the 800 mg dose causes more pronounced toxic effects but equivalent ...

As our understanding of these tumors improves, it may lead to better diagnostic and treatment protocols, ultimately enhancing patient outcomes. Gastrointestinal Stromal Tumors (GISTs): A type of ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

The aging population and lifestyle-related factors contribute to a surge in pancreatic cancer cases. The aggressive nature of the disease and its high mortality rate demand innovative therapies.

An approach using engineered small extracellular vesicles from NK cells to DR5 could be a promising strategy for solid tumors ...

A team of researchers from NUS has developed a novel method to enhance the precision of cancer treatment using gold ...

Brachytherapy stands out as a highly effective treatment option for cases where the residual disease is detected, which ...

FLC is a rare liver cancer with unique genetic traits, often misdiagnosed until advanced. New research and a clinical trial ...